239 related articles for article (PubMed ID: 10979858)
21. Modulation of gut-associated lymphoid tissue functions with genetically modified Lactococcus lactis.
Rottiers P; De Smedt T; Steidler L
Int Rev Immunol; 2009; 28(6):465-86. PubMed ID: 19954359
[TBL] [Abstract][Full Text] [Related]
22. Paracellular entry of interleukin-10 producing Lactococcus lactis in inflamed intestinal mucosa in mice.
Waeytens A; Ferdinande L; Neirynck S; Rottiers P; De Vos M; Steidler L; Cuvelier CA
Inflamm Bowel Dis; 2008 Apr; 14(4):471-9. PubMed ID: 18092343
[TBL] [Abstract][Full Text] [Related]
23. [Role of intestinal flora in inflammatory bowel disease and probiotics place in their management].
Belkahla N; Maamouri N; Ouerghi H; Ben Ammar A
Tunis Med; 2005 Mar; 83(3):132-6. PubMed ID: 15929439
[TBL] [Abstract][Full Text] [Related]
24. Intestinal flora and mucosal immune responses.
Heller F; Duchmann R
Int J Med Microbiol; 2003 Apr; 293(1):77-86. PubMed ID: 12755368
[TBL] [Abstract][Full Text] [Related]
25. Probiotics and inflammatory bowel diseases.
Bai AP; Ouyang Q
Postgrad Med J; 2006 Jun; 82(968):376-82. PubMed ID: 16754706
[TBL] [Abstract][Full Text] [Related]
26. Protective effects of lactococci strains delivering either IL-10 protein or cDNA in a TNBS-induced chronic colitis model.
del Carmen S; Martín Rosique R; Saraiva T; Zurita-Turk M; Miyoshi A; Azevedo V; de Moreno de LeBlanc A; Langella P; Bermúdez-Humarán LG; LeBlanc JG
J Clin Gastroenterol; 2014; 48 Suppl 1():S12-7. PubMed ID: 25291117
[TBL] [Abstract][Full Text] [Related]
27. Microbial therapeutics for acute colitis based on genetically modified Lactococcus lactis hypersecreting IL-1Ra in mice.
Namai F; Shigemori S; Ogita T; Sato T; Shimosato T
Exp Mol Med; 2020 Sep; 52(9):1627-1636. PubMed ID: 32989233
[TBL] [Abstract][Full Text] [Related]
28. Teaching tolerance with a probiotic antigen delivery system.
Maillard MH; Snapper SB
Gastroenterology; 2007 Aug; 133(2):706-9. PubMed ID: 17681187
[No Abstract] [Full Text] [Related]
29. Th17 Cells as Potential Probiotic Therapeutic Targets in Inflammatory Bowel Diseases.
Owaga E; Hsieh RH; Mugendi B; Masuku S; Shih CK; Chang JS
Int J Mol Sci; 2015 Sep; 16(9):20841-58. PubMed ID: 26340622
[TBL] [Abstract][Full Text] [Related]
30. Therapeutic approaches targeting intestinal microflora in inflammatory bowel disease.
Andoh A; Fujiyama Y
World J Gastroenterol; 2006 Jul; 12(28):4452-60. PubMed ID: 16874854
[TBL] [Abstract][Full Text] [Related]
31. Biologic therapy for inflammatory bowel disease.
Ardizzone S; Bianchi Porro G
Drugs; 2005; 65(16):2253-86. PubMed ID: 16266194
[TBL] [Abstract][Full Text] [Related]
32. Probiotics: a perspective on problems and pitfalls.
Shanahan F
Scand J Gastroenterol Suppl; 2003; (237):34-6. PubMed ID: 12797679
[TBL] [Abstract][Full Text] [Related]
33. Review article: the intestinal lumen as a therapeutic target in inflammatory bowel disease.
Gassull MA
Aliment Pharmacol Ther; 2006 Oct; 24 Suppl 3():90-5. PubMed ID: 16961752
[TBL] [Abstract][Full Text] [Related]
34. Immunity, inflammation, and allergy in the gut.
Macdonald TT; Monteleone G
Science; 2005 Mar; 307(5717):1920-5. PubMed ID: 15790845
[TBL] [Abstract][Full Text] [Related]
35. [Probiotics and prebiotics for the treatment of inflammatory bowel disease].
Mitsuyama K
Nihon Rinsho; 2005 May; 63(5):850-8. PubMed ID: 15881181
[TBL] [Abstract][Full Text] [Related]
36. [Probiotics for inflammatory bowel disease].
Iizuka H; Takaishi H; Hibi T
Nihon Rinsho; 2005 May; 63(5):776-80. PubMed ID: 15881169
[TBL] [Abstract][Full Text] [Related]
37. Immunomodulation by genetically engineered lactic acid bacteria.
Van Huynegem K; Loos M; Steidler L
Front Biosci (Landmark Ed); 2009 Jun; 14(13):4825-35. PubMed ID: 19482589
[TBL] [Abstract][Full Text] [Related]
38. Aetiology of inflammatory bowel disease (IBD): role of intestinal microbiota and gut-associated lymphoid tissue immune response.
Thompson-Chagoyán OC; Maldonado J; Gil A
Clin Nutr; 2005 Jun; 24(3):339-52. PubMed ID: 15896420
[TBL] [Abstract][Full Text] [Related]
39. The role of mucosal T lymphocytes in regulating intestinal inflammation.
Uhlig HH; Powrie F
Springer Semin Immunopathol; 2005 Sep; 27(2):167-80. PubMed ID: 15959782
[TBL] [Abstract][Full Text] [Related]
40. Microbes, immunoregulation, and the gut.
Rook GA; Brunet LR
Gut; 2005 Mar; 54(3):317-20. PubMed ID: 15710972
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
